A newer medication, Tirzepatide, also addresses type 2 diabetes and obesity but offers a dual-action approach by combining GLP-1 receptor agonism with GIP activation
This becomes even more difficult when dealing with conditions that may have multiple contributing factors, as is often the case with vision problems in diabetic patients
In May, i spoke to a diabetic struggling to get hold of Ozempic because of the sudden huge demand for it after the launch of weight-loss drug Wegovy was delayed in the UK
"The main theories include things like hormone disruption and obesity, [and] factors like growth factor and insulin increase the risk of cancer, also, immune system dysregulation." He continued, "The question is, how did these medications fit into that puzzle and reduce these risks?" 4
For OGTT, mice were fasted for 6 hours starting at 8 AM and gavaged with a 20% D-(+)-glucose solution (Sigma Aldrich, G7021) at 1 g/kg body weight